Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): Management with l-ornithine-l-aspartate and stent reduction

被引：0
|
作者：
Vanessa Stadlbauer
Josef Tauss
Horst R. Portugaller
Philipp Stiegler
Florian Iberer
Rudolf E. Stauber
机构：
[1] Medical University of Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology
[2] Medical University of Graz,Department of Radiology, Division of Interventional Radiology
[3] Medical University of Graz,Department of Surgery, Division of Transplantation Surgery
[4] University College London,Department of Medicine, Liver Failure Group, UCL Institute of Hepatology
来源：
Metabolic Brain Disease | 2007年 / 22卷
关键词：
Hepatic encephalopathy; Venous ammonia levels; Transjugular intrahepatic portosystemic shunt; -ornithine-; -aspartate; Stent reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Hepatic encephalopathy (HE) is a common problem after insertion of a trans-jugular intrahepatic portosystemic shunt (TIPS), which may be difficult to manage. We present a case of severe post-TIPS HE unresponsive to high doses of l-ornithine-l-aspartate (LOLA) despite reduction of venous ammonia levels in a dose-dependent fashion. Ultimately, high-grade HE was successfully treated by a reduction stent and the patient subsequently underwent successful liver transplantation.
引用
收藏
页码：45 / 50
页数：5
相关论文
共 50 条
12345